Intro Video Leonardo Ferreira
Torpedo Bio is developing a genetically engineered immune cell therapy to target solid tumors. Early models show dose response and superiority over existing treatments.
Product Video
Pitch Video
Beemok Capital and InvestSC invested $125,000 each, totaling $250,000.